written on 08.04.2014

Market Insight: A Game-Changing Agent Enters the Hepatitis C Field


Liver diseases related to hepatitis C virus (HCV) infection kill more than 350,000 people per year worldwide, and the global disease burden of HCV infections, currently estimated at 150 million individuals, is growing by 3 million to 4 million per annum. In the US alone, there are 3.2 million HCV-positive patients and a death rate […]